Especially hemizygous copy number losses of CDK7 are more frequently observed in TNBC (72%) versus other cancers (27%) [29], which co-occurs with losses in DNA damage response genes in the 5q13 region, such as RAD17 (Figure 1a). The gene discussed is CDK7; the disease is cancer.